Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Blankenstein

Showing results (21-30 of 138) with videos related to

Pageof 14
Sort By:
European Journal of Immunology|June 24, 2004
Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptorsMonika Gladow, Wolfgang Uckert, Thomas Blankenstein
Current Opinion in Immunology|October 7, 2021
The role of CD4 T cells in rejection of solid tumorsLucia Poncette, Julia Bluhm, Thomas Blankenstein
Journal for Immunotherapy of Cancer|February 23, 2023
Generation of TGFβR2(-1) neoantigen-specific HLA-DR4-restricted T cell receptors for cancer therapyNatalia Plewa, Lucia Poncette, Thomas Blankenstein
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
Dual T cell receptor expressing CD8+ T cells with tumor- and self-specificity can inhibit tumor growth without causing severe autoimmunityMonika Weinhold, Daniel Sommermeyer, Wolfgang Uckert, et al.
Current Opinion in Immunology|March 3, 2015
Targeting cancer-specific mutations by T cell receptor gene therapyThomas Blankenstein, Matthias Leisegang, Wolfgang Uckert, et al.
Cancer Metastasis Reviews|October 17, 2014
Function and regulation of MTA1 and MTA3 in malignancies of the female reproductive systemAnsgar Brüning, Thomas Blankenstein, Julia Jückstock, et al.
The Journal of Clinical Investigation|January 26, 2016
Targeting human melanoma neoantigens by T cell receptor gene therapyMatthias Leisegang, Thomas Kammertoens, Wolfgang Uckert, et al.
MMW Fortschritte Der Medizin|January 22, 2020
[Often not requiring therapy]Julia Jückstock, Thomas Blankenstein, Fabian Weiß, et al.
Transgenic Research|December 15, 2011
Depot formation of doxycycline impairs Tet-regulated gene expression in vivoKathleen Anders, Christian Buschow, Jehad Charo, et al.
The Journal of Experimental Medicine|June 5, 2002
Inhibition of methylcholanthrene-induced carcinogenesis by an interferon gamma receptor-dependent foreign body reactionZhihai Qin, Hye-Jung Kim, Jens Hemme, et al.
Pageof 14

Showing results (21-30 of 138) with videos related to

Sort By:
Pageof 14
European Journal of Immunology|June 24, 2004
Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptorsMonika Gladow, Wolfgang Uckert, Thomas Blankenstein
Current Opinion in Immunology|October 7, 2021
The role of CD4 T cells in rejection of solid tumorsLucia Poncette, Julia Bluhm, Thomas Blankenstein
Journal for Immunotherapy of Cancer|February 23, 2023
Generation of TGFβR2(-1) neoantigen-specific HLA-DR4-restricted T cell receptors for cancer therapyNatalia Plewa, Lucia Poncette, Thomas Blankenstein
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
Dual T cell receptor expressing CD8+ T cells with tumor- and self-specificity can inhibit tumor growth without causing severe autoimmunityMonika Weinhold, Daniel Sommermeyer, Wolfgang Uckert, et al.
Current Opinion in Immunology|March 3, 2015
Targeting cancer-specific mutations by T cell receptor gene therapyThomas Blankenstein, Matthias Leisegang, Wolfgang Uckert, et al.
Cancer Metastasis Reviews|October 17, 2014
Function and regulation of MTA1 and MTA3 in malignancies of the female reproductive systemAnsgar Brüning, Thomas Blankenstein, Julia Jückstock, et al.
The Journal of Clinical Investigation|January 26, 2016
Targeting human melanoma neoantigens by T cell receptor gene therapyMatthias Leisegang, Thomas Kammertoens, Wolfgang Uckert, et al.
MMW Fortschritte Der Medizin|January 22, 2020
[Often not requiring therapy]Julia Jückstock, Thomas Blankenstein, Fabian Weiß, et al.
Transgenic Research|December 15, 2011
Depot formation of doxycycline impairs Tet-regulated gene expression in vivoKathleen Anders, Christian Buschow, Jehad Charo, et al.
The Journal of Experimental Medicine|June 5, 2002
Inhibition of methylcholanthrene-induced carcinogenesis by an interferon gamma receptor-dependent foreign body reactionZhihai Qin, Hye-Jung Kim, Jens Hemme, et al.
Pageof 14